BNGO vs EYPT: stock comparison and AI forecast
Bionano Genomics, Inc. (BNGO) and Eyepoint, Inc. (EYPT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BNGO Bionano Genomics, Inc.
- Market Cap
- $13M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
EYPT Eyepoint, Inc.
- Market Cap
- $31M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- EYPT is 2.4 times larger than BNGO by market capitalization ($31M against $13M).
- BNGO turns -106.6% of its revenue into net income, against -10998.7% for EYPT.
- BNGO carries 0.51 times debt per unit of equity, against 0.37 times for EYPT.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BNGO | EYPT |
|---|---|---|
| Market Cap | $13M | $31M |
| P/B Ratio | 0.41x | 0.19x |
| EPS | $-2.35 | $-3.41 |
| Book Value/Share | $2.68 | $1.93 |
| Revenue/Share | $2.56 | $0.03 |
| FCF/Share | – | $-3.15 |
Profitability & Margins
| Metric | BNGO | EYPT |
|---|---|---|
| ROE | -101.8% | -184.3% |
| ROA | -67.6% | -134.4% |
| ROIC | -85.7% | -170.2% |
| Gross Margin | 47.5% | – |
| Operating Margin | -106.7% | -11369.3% |
| Net Margin | -106.6% | -10998.7% |
| EBT Margin | -106.4% | -10947.2% |
| Tax Rate | -0.2% | -0.0% |
Financial Health
| Metric | BNGO | EYPT |
|---|---|---|
| Current Ratio | 2.48x | 4.50x |
| Quick Ratio | 1.78x | 4.46x |
| D/E Ratio | 0.51x | 0.37x |
| Financial Leverage | 1.51x | 1.37x |
| Interest Coverage | -29.5x | -52.3x |
| Working Capital | $15M | $147M |
Cash Flow
| Metric | BNGO | EYPT |
|---|---|---|
| Operating Cash Flow | -$20M | -$267M |
| Free Cash Flow | – | -$271M |
| Capital Spending | – | -$4M |
| FCF/Sales | – | -9730.2% |
| CapEx/Sales | – | 142.8% |
Operational Efficiency
| Metric | BNGO | EYPT |
|---|---|---|
| Asset Turnover | 0.63x | 0.01x |
| Receivables Turnover | 6.9x | – |
| Inventory Turnover | 2.3x | – |
| Fixed Assets Turnover | 2.3x | 0.3x |
| Days Sales Outstanding | 53 days | – |
| Days Inventory | 162 days | – |
| Payables Period | 105 days | – |
| Cash Conversion Cycle | 109 days | – |
Income Statement
| Metric | BNGO | EYPT |
|---|---|---|
| Total Revenue | $30M | $3M |
| Operating Income | -$32M | -$317M |
| Net Income | -$32M | -$307M |
| R&D Expense | $12M | $263M |
| SG&A Expense | $34M | $130M |
| Cost of Goods Sold | $16M | – |
Dividend & Shareholder Information
| Metric | BNGO | EYPT |
|---|---|---|
| Shares Outstanding | 12M | 86M |
BNGO vs EYPT: stock comparison and AI forecast
Which is bigger, BNGO or EYPT?
EYPT is 2.4 times larger than BNGO by market capitalization ($31M against $13M).
Which one does Intratio's AI model rank higher, BNGO or EYPT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.